[
  {
    "ts": null,
    "headline": "Biogen Faces Uncertain Outlook for Alzheimer's Drug But Pipeline Supports Growth, RBC Says",
    "summary": "Biogen's (BIIB) new Alzheimer's drug, BIIB080, has mid-year results coming up and its success is unc",
    "url": "https://finnhub.io/api/news?id=989b789e0cd5bf0671707091c075df26571131b03e44c5cce957481506efa455",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772126232,
      "headline": "Biogen Faces Uncertain Outlook for Alzheimer's Drug But Pipeline Supports Growth, RBC Says",
      "id": 139237020,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biogen's (BIIB) new Alzheimer's drug, BIIB080, has mid-year results coming up and its success is unc",
      "url": "https://finnhub.io/api/news?id=989b789e0cd5bf0671707091c075df26571131b03e44c5cce957481506efa455"
    }
  }
]